Antimicrobial drug discovery through bacteriophage genomics

Nature Biotechnology

Volumn 22, Issue 2, 2004, Pages 185-191

  Liu, Jing ^a   Dehbi, Mohammed ^a   Moeck, Greg ^a   Arhin, Francis ^a   Banda, Pascale ^a   Bergeron, Dominique ^a   Callejo, Mario ^a   Ferretti, Vincent ^a   Ha, Nhuan ^a   Kwan, Tony ^a   McCarty, John ^a   Srikumar, Ramakrishnan ^a   Williams, Dan ^a   Wu, Jinzi J ^a   Gros, Philippe ^b   Pelletier, Jerry ^b   DuBow, Michael ^b,c  

^a PhageTech Inc   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; CELLS; DNA; DRUG PRODUCTS; GENES;

ANTIMICROBIAL DRUGS;

BIOTECHNOLOGY;

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; DNA; GLUTATHIONE TRANSFERASE; HELICASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN DNAI; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIOPHAGE; CONTROLLED STUDY; DNA REPLICATION; DNA SEQUENCE; DNA SYNTHESIS INHIBITION; DRUG DISCOVERY; DRUG RESEARCH; DRUG SCREENING; GENOMICS; HOST RESISTANCE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RNA TRANSCRIPTION; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS; UNIDENTIFIED BACTERIOPHAGE;

EID: 0742323372     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt932     Document Type: Article

References (39)

1. Salgado, C.D., Farr, B.M. & Calfee, D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin. Infect. Dis. 36, 131-139 (2003).
2. Tenover, F.C., Biddle, J.W. & Lancaster, M.V. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis. 7, 327-332 (2001).
3. Khare, M. & Keady, D. Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection. Expert Opin. Pharmacother. 4, 165-177 (2003).
4. Kuroda, M. et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357, 1225-1240 (2001).
5. Moir, D.T., Shaw, K.J., Hare, R.S. & Vovis, G.F. Genomics and antimicrobial drug discovery. Antimicrob. Agents Chemother. 43, 439-446 (1999).
6. McDevitt, D. & Rosenberg, M. Exploiting genomics to discover new antibiotics. Trends Microbiol. 9, 611-617 (2001).
7. Ji, Y. et al. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293, 2266-2269 (2001).
8. Forsyth, R.A. et al. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol. Microbiol. 43, 1387-1400 (2002).
9. Kobayashi, K. et al. Essential Bacillus subtilis genes. Proc. Natl. Acad. Sci. USA 100, 4678-4683 (2003).
10. Nechaev, S. & Severinov, K. Inhibition of Escherichia coli RNA polymerase by bacteriophage T7 gene 2 protein. J. Mol. Biol. 289, 815-826 (1999).
11. Orsini, G., Ouhammouch, M., Le Caer, J.P. & Brody, E.N. The asiA gene of bacteriophage T4 codes for the anti-sigma 70 protein. J. Bacteriol. 175, 85-93 (1993).
12. Mallory, J.B., Altano, C. & McMacken, R. Host virus interactions in the initiation of bacteriophage lambda DNA replication. Recruitment of Escherichia coli DnaB helicase by lambda P replication protein. J. Biol. Chem. 265, 13297-13307 (1990).
13. Odegrip, R., Schoen, S., Haggard-Ljungquist, E., Park, K. & Chattoraj, D.K. The interaction of bacteriophage P2 B protein with Escherichia coli DnaB helicase. J. Virol. 74, 4057-4063 (2000).
14. Biswas, B. et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70, 204-210 (2002).
15. Stone, R. Bacteriophage therapy. Stalin's forgotten cure. Science 298, 728-731 (2002).
16. Schuch, R., Nelson, D. & Fischetti, V.A. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884-889 (2002).
17. Loeffler, J.M., Nelson, D. & Fischetti, V.A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170-2172 (2001).
18. Ackermann, H.-W. & DuBow, M.S. Viruses of Prokaryotes, vol. 2 (CRC Press, Boca Raton, Florida, 1987).
19. Kaneko, J., Kimura, T., Narita, S., Tomita, T. & Kamio, Y. Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes. Gene 215, 57-67 (1998).
20. Tauriainen, S., Karp, M., Chang, W. & Virta, M. Recombinant luminescent bacteria for measuring bioavailable arsenite and antimonite. Appl. Environ. Microbiol. 63, 4456-4461 (1997).
21. Kreiswirth, B.N. et al. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305, 709-712 (1983).
22. Wang, I.N., Smith, D.L. & Young, R. Holins: the protein clocks of bacteriophage infections. Annu. Rev. Microbiol. 54, 799-825 (2000).
23. Young, I., Wang, I. & Roof, W.D. Phages will out: strategies of host cell lysis. Trends Microbiol. 8, 120-128 (2000).
24. Sonnhammer, E.L., von Heijne, G. & Krogh, A. A hidden Markov model for predicting transmembrane helices in protein sequences. Proc. Int. Conf. Intell. Syst. Mol. Biol. 6, 175-182 (1998).
25. Simpson, R.J. Proteins and proteomics: a laboratory manual (Cold Spring Harbor Laboratory Press, New York, 2002).
26. Bruand, C., Farache, M., McGovern, S. Ehrlich, S.D. & Polard, P. DnaB, DnaD and Dnal proteins are components of the Bacillus subtilis replication restart primosome. Mol. Microbiol. 42, 245-255 (2001).
27. Marsin, S., McGovern, S., Ehrlich, S. O., Bruand, C. & Polard, P. Early steps of Bacillus subtilis primosome assembly. J. Biol. Chem. 276, 45818-45825 (2001).
28. Velten, M. et al. A two-protein strategy for the functional loading of a cellular replicative DNA helicase. Mol. Cell 11, 1009-102O (2003).
29. Mathis, G. Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer. Clin. Chem. 41, 1391-1397 (1995).
30. Jana, M., Luong, T.T., Komatsuzawa, H., Shigeta, M. & Lee, C.Y. A method for demonstrating gene essentiality in Staphylococcus aureus. Plasmid 44, 100-104 (2000).
31. Walsh, C. Antibiotics: Actions, Origins Resistance (ASM Press, Washington, DC, 2003).
32. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A laboratory manual, edn. 2 (Cold Spring Harbor Laboratory Press, New York, 1989).
33. Adams, M.H. Bacteriophages (Interscience Publishers, New York, NY, 1959).
34. Schenk, S. & Laddaga, R.A. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol. Lett. 73, 133-138 (1992).
35. Methot, N., Song, M.S. & Sonenberg, N. A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (elF4B) self-association and interaction with elF3. Mol. Cell Biol. 16, 5328-5334 (1996).
36. Kaelin, W.G., Jr. et al. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70, 351-364 (1992).
37. De Crescenzo, G., Grothe, S., Lortie, R., Debanne, M.T. & O'Connor-McCourt, M. Real-time kinetic studies on the interaction of transforming growth factor alpha with the epidermal growth factor receptor extracellular domain reveal a conformational change model. Biochemistry 39, 9466-9476 (2000).
38. NCCLS specialty collection: susceptibility testing, edn. 5 (NCCLS, Wayne, PA, 2000).
39. Kaito, C., Kurokawa, K., Hossain, M.S., Akimitsu, N. & Sekimizu, K. Isolation and characterization of temperature-sensitive mutants of the Staphylococcus aureus dnaC gene. FEMS Microbiol. Lett. 210, 157-164 (2002).